Identification of biomarkers for preterm delivery in mid-trimester amniotic fluid

Placenta

Volumn 34, Issue 10, 2013, Pages 873-878

  Kim, A ^a   Lee, E S ^b   Shin, J C ^c   Kim, H Y ^d  

^a Wonkwang University School of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Kangwon National University College of Medicine   (South Korea)

^d Kosin University   (South Korea)

Author keywords

Amniotic fluid; IL 6; MMP 8; Preterm birth; VEGF

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; VASCULOTROPIN;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; PREDICTIVE VALUE; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; WESTERN BLOTTING;

AMNIOTIC FLUID; IL-6; MMP-8; PRETERM BIRTH; VEGF;

ADULT; AMNIOTIC FLUID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 8; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888303236     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2013.06.306     Document Type: Article

References (30)

1. Krupa FG, Faltin D, Cecatti JG, Surita FG, Souza JP. Predictors of preterm birth. Int J Gynaecol Obstet 2006;94(1):5-11.
2. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371(9606):75-84.
3. Conde Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: A systematic review and meta-analysis. BJOG 2011;118(9):1042-54.
4. Defranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: Is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth A systematic review. Am J Obstet Gynecol 2013;208(3):233.e1-6.
5. Kim Y, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med 2013;91(3):323-8.
6. Gervasi M, Romero R, Bracalente G, Erez O, Dong Z, Hassan S, et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferongamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (32 weeks) preterm delivery. J Perinat Med 2012;40(4):329-43.
7. Borna S, Abdollahi A, Mirzaei F. Predictive value of mid-trimester amniotic fluid high-sensitive C-reactive protein, ferritin, and lactate dehydrogenase for fetal growth restriction. Indian J Pathol Microbiol 2009;52(4):498-500.
8. Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, DEril GV, et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am J Obstet Gynecol 2002;186(2):268-73.
9. Spong CY, Sherer DM, Ghidini A, Jenkins CB, Seydel FD, Eglinton GS. Secondtrimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates. Obstet Gynecol 1996;88(1):24-8.
10. Spong CY, Scherer DM, Ghidini A, Pezzullo JC, Salafia CM, Eglinton GS. Midtrimester amniotic fluid tumor necrosis factor-alpha does not predict smallfor-gestational-age infants. Am J Reprod Immunol 1997;37(3):236-9.
11. Ghidini A, Jenkins CB, Spong CY, Pezzullo JC, Salafia CM, Eglinton GS. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol 1997;37(3):227-31.
12. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Matern Fetal Neonatal Med 2005;18(4):241-7.
13. Apuzzio J, Chan Y, Al Khan A, Illsley N, Kim P, Vonhaggen S. Second-trimester amniotic fluid interleukin-10 concentration predicts preterm delivery. J Matern Fetal Neonatal Med 2004;15(5):313-7.
14. Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001;185(5):1162-7.
15. Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998;178(3):546-50.
16. Pressman EK, Thornburg L, Glantz JC, Earhart A, Wall PD, Ashraf M, et al. Inflammatory cytokines and antioxidants in midtrimester amniotic fluid: correlation with pregnancy outcome. Am J Obstet Gynecol 2011;204(2):155.e1-7.
17. Bamberg C, Fotopoulou C, Thiem D, Roehr C, Dudenhausen JW, Kalache KD. Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia. J Matern Fetal Neonatal Med 2012;25(6):812-7.
18. Bamberg C, Fotopoulou C, Linder M, Roehr CC, Dudenhausen JW, Henrich W, et al. Mid-trimester amniotic fluid concentrations of the proinflammatory cytokines IL-6, IL-8, TNF-Î-, and lipopolysaccharide binding protein in normal pregnancies: A prospective evaluation according to parity, gestational age, and fetal gender. J Perinat Med 2011;39(4):403-9.
19. Snegovskikh V, Schatz F, Arcuri F, Toti P, Kayisli UA, Murk W, et al. Intraamniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and-2 expression: Implications for infectionrelated preterm birth. Reprod Sci 2009;16(8):767-80.
20. Ozer KT, Kavak ZN, GÃkaslan H, Elter K, Pekin T. Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery. Eur J Obstet Gynecol Reprod Biol 2005;122(2):187-90.
21. Maymon E, Romero R, Pacora P, Gomez R, Athayde N, Edwin S, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000;183(1):94-9.
22. Weissenbacher T, Laubender RP, Witkin S, Gingelmaier A, Schiessl B, Kainer F, et al. Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth. Arch Gynecol Obstet 2013;287(4):673-85.
23. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993;81(6):941-8.
24. Sadowsky DW, Adams KM, Gravett MG, Witkin S, Novy MJ. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006;195(6):1578-89.
25. Costa C, Incio J, Soares R. Angiogenesis and chronic inflammation: cause or consequence Angiogenesis 2007;10:149-66.
26. Kundu JK, Surh Y. Emerging avenues linking inflammation and cancer. Free Radic Biol Med 2012;52(3):2013-37.
27. Stannard AK, Khurana R, Evans IM, Sofra V, Holmes DI, Zachary I. Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 2007;27(3):494-502.
28. Krikun G, Huang SJ, Schatz F, Salafia C, Stocco C, Lockwood CJ. Thrombin activation of endometrial endothelial cells: A possible role in intrauterine growth restriction. Thromb Haemost 2007;97(2):245-53.
29. Brou L, Almli LM, Pearce BD, Bhat G, Drobek CO, Fortunato S, et al. Dysregulated biomarkers induce distinct pathways in preterm birth. BJOG 2012;119(4):458-73.
30. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, et al. The preterm parturition syndrome. BJOG 2006;113(Suppl. 3):17-42.